GR3020502T3 - Controlled release formulations - Google Patents

Controlled release formulations

Info

Publication number: GR3020502T3
Authority: GR; Greece
Prior art keywords: complex; active agent; composition; polycarbophil; polymeric
Prior art date: 1990-08-21

Application number

GR960401871T

Other languages

English (en)

Inventor

Ramesh N Acharya

Original Assignee

Theratech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-21

Filing date

1996-07-10

Publication date

1996-10-31

1990-08-21 Priority claimed from US07/570,340 external-priority patent/US5110605A/en

1990-09-11 Priority claimed from US07/580,854 external-priority patent/US5102666A/en

1991-04-01 Priority claimed from US07/678,814 external-priority patent/US5686094A/en

1996-07-10 Application filed by Theratech Inc filed Critical Theratech Inc

1996-10-31 Publication of GR3020502T3 publication Critical patent/GR3020502T3/el

Links

239000000203 mixture Substances 0.000 title abstract 5
238000013270 controlled release Methods 0.000 title abstract 2
238000009472 formulation Methods 0.000 title 1
239000013543 active substance Substances 0.000 abstract 4
229920000148 Polycarbophil calcium Polymers 0.000 abstract 3
229950005134 polycarbophil Drugs 0.000 abstract 3
239000003795 chemical substances by application Substances 0.000 abstract 2
239000002537 cosmetic Substances 0.000 abstract 2
230000003993 interaction Effects 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
208000005946 Xerostomia Diseases 0.000 abstract 1
229960001126 alginic acid Drugs 0.000 abstract 1
235000010443 alginic acid Nutrition 0.000 abstract 1
229920000615 alginic acid Polymers 0.000 abstract 1
239000000783 alginic acid Substances 0.000 abstract 1
150000004781 alginic acids Chemical class 0.000 abstract 1
150000001768 cations Chemical class 0.000 abstract 1
239000006184 cosolvent Substances 0.000 abstract 1
206010013781 dry mouth Diseases 0.000 abstract 1
238000003780 insertion Methods 0.000 abstract 1
230000037431 insertion Effects 0.000 abstract 1
210000004400 mucous membrane Anatomy 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8194—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds; Compositions of derivatives of such polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Birds (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Oral & Maxillofacial Surgery (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Lubricants (AREA)

GR960401871T 1990-08-21 1996-07-10 Controlled release formulations GR3020502T3 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US07/570,340 US5110605A (en)	1990-08-21	1990-08-21	Calcium polycarbophil-alginate controlled release composition and method
US07/580,854 US5102666A (en)	1990-09-11	1990-09-11	Calcium polycarbophil controlled release composition and method
US07/678,814 US5686094A (en)	1991-04-01	1991-04-01	Controlled release formulations for the treatment of xerostomia
PCT/US1991/005955 WO1992003124A1 (en)	1990-08-21	1991-08-20	Controlled release formulations and method

Publications (1)

Publication Number	Publication Date
GR3020502T3 true GR3020502T3 (en)	1996-10-31

Family

ID=27416097

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR960401871T GR3020502T3 (en)	1990-08-21	1996-07-10	Controlled release formulations

Country Status (9)

Country	Link
EP (1)	EP0497956B1 (el)
JP (1)	JP3064417B2 (el)
AT (1)	ATE137404T1 (el)
AU (1)	AU8444291A (el)
DE (1)	DE69119217T2 (el)
DK (1)	DK0497956T3 (el)
ES (1)	ES2088500T3 (el)
GR (1)	GR3020502T3 (el)
WO (1)	WO1992003124A1 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5661171A (en) *	1992-07-02	1997-08-26	Oramed, Inc.	Controlled release pilocarpine delivery system
EP0659077A1 (en) *	1992-07-02	1995-06-28	TheraTech, Inc.	Controlled release pilocarpine delivery system
DE69330797T2 (de) *	1993-01-19	2002-05-23	The Gillette Co., Boston	Mundwasser
US5885552A (en) *	1993-01-19	1999-03-23	Gillette Canada Inc.	Mouthrinse
GB2279871B (en) *	1993-06-23	1997-05-07	Jevco Ltd	Drug retention systems for use in aquaculture
US6548084B2 (en)	1995-07-20	2003-04-15	Smithkline Beecham Plc	Controlled release compositions
GB9514842D0 (en) *	1995-07-20	1995-09-20	Smithkline Beecham Plc	Novel formulation
AU748804B2 (en) *	1995-07-20	2002-06-13	Smithkline Beecham Plc	Paroxetine controlled release compositions
US5912007A (en) *	1996-02-29	1999-06-15	Warner-Lambert Company	Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same
IT1284874B1 (it) *	1996-08-02	1998-05-22	Farmigea Spa	Complessi bioadesivi di polycarbophil e farmaci antifungini o antiprotozoari azolici
DE19637792A1 (de) *	1996-09-17	1998-03-19	Huels Chemische Werke Ag	Katalysator und Verfahren zur katalytischen Abgasreinigung im DMT-Prozeß
JP4850709B2 (ja) *	2003-05-14	2012-01-11	ダニスコ・ユーエス・インコーポレーテッド	反復配列タンパク質ポリマーを使用する、活性剤の制御放出
ES2344911T3 (es)	2004-08-02	2010-09-09	Glaxo Group Limited	Composicion novedosa para tratar la xerostomia.
US20060045865A1 (en) *	2004-08-27	2006-03-02	Spherics, Inc.	Controlled regional oral delivery
WO2007017712A1 (en) *	2005-08-11	2007-02-15	Promedon Do Brasil Produtos Medico-Hospitalares Ltda.	Composition comprising polymeric, water-insoluble, anionic particles, processes and uses
TW201010743A (en) *	2008-09-05	2010-03-16	Otsuka Pharma Co Ltd	Pharmaceutical solid preparation
EP3145548B1 (en)	2014-05-22	2022-04-13	University of Copenhagen	Aqueous gel composition and its use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0830004B2 (ja) *	1983-11-14	1996-03-27	コロンビアラボラトリーズインコーポレイテッド	生物接着性組成物およびそれにより治療する方法
IE63392B1 (en) *	1988-02-08	1995-04-19	Insite Vision Inc	Ophthalmic suspensions
CA2003808C (en) *	1988-11-28	1999-11-09	Eugene Joseph Sehm	Crosslinked polyacrylic acid
US4988679A (en) *	1989-01-03	1991-01-29	Leonard Chavkin	Liquid sustained release composition
HU227563B1 (en) *	1989-10-31	2011-08-29	Columbia Lab Bermuda Ltd	Process for production of composition for moisturizing of tissue

1991
- 1991-08-20 AT AT91915434T patent/ATE137404T1/de not_active IP Right Cessation
- 1991-08-20 EP EP91915434A patent/EP0497956B1/en not_active Expired - Lifetime
- 1991-08-20 DK DK91915434.4T patent/DK0497956T3/da active
- 1991-08-20 AU AU84442/91A patent/AU8444291A/en not_active Abandoned
- 1991-08-20 ES ES91915434T patent/ES2088500T3/es not_active Expired - Lifetime
- 1991-08-20 JP JP3514547A patent/JP3064417B2/ja not_active Expired - Fee Related
- 1991-08-20 DE DE69119217T patent/DE69119217T2/de not_active Expired - Fee Related
- 1991-08-20 WO PCT/US1991/005955 patent/WO1992003124A1/en not_active Ceased
1996
- 1996-07-10 GR GR960401871T patent/GR3020502T3/el unknown

Also Published As

Publication number	Publication date
DK0497956T3 (da)	1996-08-12
JPH05502894A (ja)	1993-05-20
EP0497956A1 (en)	1992-08-12
ES2088500T3 (es)	1996-08-16
JP3064417B2 (ja)	2000-07-12
EP0497956A4 (en)	1993-03-31
EP0497956B1 (en)	1996-05-01
WO1992003124A1 (en)	1992-03-05
ATE137404T1 (de)	1996-05-15
DE69119217D1 (de)	1996-06-05
AU8444291A (en)	1992-03-17
DE69119217T2 (de)	1996-10-31

Publication	Publication Date	Title
AU8444291A (en)	1992-03-17	Controlled release formulations and method
GB9220667D0 (en)	1992-11-11	Improvements in or relating to dioic acids
IT1255390B (it)	1995-10-31	Prodotti farmaceutici per curare malattie tumorali e procedimento per la loro preparazione
MX9306239A (es)	1994-06-30	Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma.
ATE124261T1 (de)	1995-07-15	Zusammensetzung in form eines schaumes enthaltend 5-aminosalicylic säure zur intra-rektal verabreichung.
DE59209658D1 (de)	1999-04-22	Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung
ATE209907T1 (de)	2001-12-15	Flüssige mittel zur wirkstoffabgabe
ES8701390A1 (es)	1986-11-16	Un procedimiento para tratar lentes de contacto.
ATE202923T1 (de)	2001-07-15	Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
SE7501464L (el)	1975-08-12
DE69615400D1 (de)	2001-10-25	5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen
AU8091787A (en)	1988-05-12	The use of paroxetine to treat pain
DE69025271D1 (de)	1996-03-21	Pharmazeutische Zubereitungen mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen
NZ506681A (en)	2002-12-20	Disinfecting composition
DE59002748D1 (de)	1993-10-21	Verfahren zur Herstellung von Mitteln zur Therapie von Hauterkrankungen.
MY104521A (en)	1994-04-30	Treatment of depression.
AU1777595A (en)	1995-11-09	Methods for treating neurofibromatosis
DE3276786D1 (en)	1987-08-27	Medical process and preparation
US4250167A (en)	1981-02-10	Methods for reducing calcium deposits
DE69129232D1 (de)	1998-05-14	Zusammensetzung aus asphodelus zur erhöhung der anzahl weisser blutzellen
HUT49809A (en)	1989-11-28	Process for producing pharmaceutical composition for treating miohypoplasia of young pigs
SG49645A1 (en)	1999-10-19	A method of treating liver disease and like indications with vasodilating agents
ATE345138T1 (de)	2006-12-15	Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen
UA10281C2 (uk)	2000-11-15	Спосіб отримання речовини для лікування захворювань підшлункової залози
BG50660A1 (en)	1992-10-15	Method for polyethylene oxide neutralization and stabilization